AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
Meet Matthew Doenges: A Managed Care Resident
Matthew Doenges, PharmD, MS, is a Value & Evidence Strategy (HEOR) Post-Doctoral Fellow at Alnylam Pharmaceuticals
"I've never been involved with a professional organization that really focuses on giving back to the students and their professional development. I've certainly felt that along my professional journey and as I make a transition or change to a full time employee, that's my next initiative: to help the other pharmacy students who were in my shoes not too long ago."
Related
To discuss navigating the rapidly changing landscape of ER+/HER2− metastatic breast cancer (mBC), AMCP Market Insights virtually convened an expert panel of managed care stakeholders in February 2025.
To discuss managed care approaches to bsAbs with a focus on FL and DLBCL, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2025.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
